Primary Site >> Liver Cancer
Gene >> SARS2
| 1. | |||||||||||
| Journal: | J Clin Oncol. 2003 Feb 1;21(3):406-12. | ||||||||||
| Title: | Thymidylate synthase expression in hepatic tumors is a predictor of survival and progression in patients with resectable metastatic colorectal cancer. | ||||||||||
| Author: | Gonen, Mithat|Hummer, Amanda|Zervoudakis, Alice|Sullivan, Deidre|Fong, Yuman|Banerjee, Debabrata|Klimstra, David|Cordon-Cardo, Carlos|Bertino, Joseph|Kemeny, Nancy | ||||||||||
| PMID: | 12560427 | ||||||||||
| 2. | |||||||||||
| Journal: | Gan To Kagaku Ryoho. 2010 Nov;37(12):2267-70. | ||||||||||
| Title: | [Prehepatectomy chemotherapy using hepatic artery infusion plus systemic chemotherapy for liver metastases from colorectal cancer]. | ||||||||||
| Author: | Tanaka, Kuniya|Kumamoto, Takafumi|Nojiri, Kazunori|Mori, Ryotaro|Matsuyama, Ryusei|Takeda, Kazuhisa|Ota, Mitsuyoshi|Akiyama, Hirotoshi|Ichikawa, Yasushi|Endo, Itaru | ||||||||||
| PMID: | 21224543 | ||||||||||
| 3. | |||||||||||
| Journal: | Int J Colorectal Dis. 2013 Apr;28(4):555-62. | ||||||||||
| Title: | Hepatic arterial infusion but not systemic application of cetuximab in combination with oxaliplatin significantly reduces growth of CC531 colorectal rat liver metastases. | ||||||||||
| Author: | Sperling, Jens|Schafer, Thilo|Benz-Weisser, Anna|Ziemann, Christian|Scheuer, Claudia|Kollmar, Otto|Schilling, Martin K|Menger, Michael D | ||||||||||
| PMID: | 23242249 | ||||||||||
| 4. | |||||||||||
| Journal: | Ann Surg Oncol. 2014 Feb;21(2):479-86. | ||||||||||
| Title: | Floxuridine hepatic arterial infusion associated biliary toxicity is increased by concurrent administration of systemic bevacizumab. | ||||||||||
| Author: | Cercek, Andrea|D'Angelica, Michael|Power, Derek|Capanu, Marinela|Gewirtz, Alexandra|Patel, Dina|Allen, Peter|Fong, Yuman|DeMatteo, Ronald P|Jarnagin, William R|Kemeny, Nancy E | ||||||||||
| PMID: | 24154839 | ||||||||||
| 5. | |||||||||||
| Journal: | Mikrochim Acta. 2018 Jan 8;185(2):90. | ||||||||||
| Title: | Direct determination of the tumor marker AFP via silver nanoparticle enhanced SERS and AFP-modified gold nanoparticles as capturing substrate. | ||||||||||
| Author: | Zhang, Chenmeng|Gao, Yukun|Yang, Nan|You, Tingting|Chen, Huaxiang|Yin, Penggang | ||||||||||
| PMID: | 29594421 | ||||||||||